Hair has always been more than just a style—especially in the Black community, where our coils, curls, and protective styles ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

Everyone’s alopecia areata is different. Even though everyone who has it experiences hair loss, it may have many variations, including where, when, and how often you lose your hair. Alopecia ...

Alopecia areata can make both your professional and personal life hard to navigate. Research has found that as many as 1 in 6 people are uncomfortable having contact with someone who has hair ...

A dermatologist diagnosed her with alopecia areata, an autoimmune disease that causes hair loss on the scalp, face and sometimes elsewhere on the body, ...

Alopecia areata affects millions of Americans regardless of age, race, or gender, manifesting as patchy hair loss across the scalp and sometimes other body areas. This autoimmune condition occurs ...

Patients with severe alopecia areata were less likely to have complete improvement (0% vs 33.3%; P = .01) or any improvement (50% vs 84.9%; P = .02) compared with the nonsevere cohort.

Shamsha Damani has lived with alopecia areata since she was six, which turned into alopecia universalis in 2013. She's a fierce advocate for those with alopecia areata and currently serves on the ...

Alopecia areata risk also has possible positive correlations with levels of N-acetylarginine (OR, 1.31; 95% CI, 1.03-1.65; P = .025) and 12 additional serum metabolites.

Ashley Tisdale opens up to PEOPLE in an exclusive interview about how she changed her haircare routine after she was diagnosed with alopecia areata in her mid-20s.

At the time of alopecia areata diagnosis, 30.9% of patients had psychiatric comorbidities compared with 26.8% of unmatched controls without alopecia areata (P<0.001), while 16.1% versus 8.9% ...